ANDA 210026, held by Aurobindo Pharma Ltd. Apixaban.
As of Nov 15, 2026, ANDA 210026 (Apixaban), held by Aurobindo Pharma Ltd, was first approved by FDA on May 26, 2023, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 26, 2023 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
